Cancer immunotherapy: Progress and challenges in the clinical setting

Eur J Immunol. 2011 Jun;41(6):1510-5. doi: 10.1002/eji.201190035.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, Neoplasm / immunology
  • Antineoplastic Agents / pharmacology
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Drug Discovery
  • Genetic Engineering
  • Humans
  • Immunotherapy* / trends
  • Neoplasms / immunology*
  • Neoplasms / mortality
  • Neoplasms / therapy*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Survivors
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / transplantation

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antineoplastic Agents